US Stock MarketDetailed Quotes

NBIX Neurocrine Biosciences

Watchlist
  • 141.980
  • +2.900+2.09%
Trading Jul 8 15:42 ET
14.29BMarket Cap38.58P/E (TTM)

Neurocrine Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neurocrine Biosciences Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 1, 2024

Revenue(YoY)

515.30M

+22.57%
EPS(YoY)

0.42

+153.16%
Analyst Rating

Strong Buy

Jul 8, 2024

Neurocrine Biosciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 21 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 569.854M--
--2024/Q2-- / 547.793M--
May 1, 20242024/Q1515.300M / 512.006M--
Feb 7, 20242023/Q4515.200M / 518.389M--
Oct 31, 20232023/Q3498.800M / 479.026M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 569.854M--
--2024/Q2-- / 547.793M--
May 1, 20242024/Q1515.300M / 512.006M--
Feb 7, 20242023/Q4515.200M / 518.389M--
Oct 31, 20232023/Q3498.800M / 479.026M--

Unlock Free Earnings Estimates

Neurocrine Biosciences Earnings Reports

  • Neurocrine Biosciences | 10-Q: Quarterly report

    May 1 19:09

  • Neurocrine Biosciences | 10-K: Annual report

    Feb 10 06:31

  • Neurocrine Biosciences | 10-Q: Q3 2023 Earnings Report

    Oct 31, 2023 19:02

  • Neurocrine Biosciences | 10-Q: Q2 2023 Earnings Report

    Aug 1, 2023 19:03

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 8, 2024

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg